Company intelligence

APYX

Apyx Medical Corporation · NASDAQ · Healthcare

Price$2.95+0.00% · +$0.00

Market cap124.23MEquity value

P / E-14.8Trailing ratio

Volume86.06KLatest session

Market data

APYX price chart

TradingView

Related signals

1 min delayed

Browse public APYX signals with their source context and measured market impact. Open any signal for its permanent analysis page.

APYXMay 4, 2026-4.45% since signal

Aesthetic Sector Set for Growth Amid GLP-1 Obesity Drug Side Effects

The aesthetic sector is poised for growth as patients experience side effects like loose skin and facial volume loss from GLP-1 obesity drugs, creating increased demand for treatment. This trend may positively impact earnings as firms report their first-quarter performance, presenting potential investment opportunities in companies like APYX.

View signal analysis

APYXMay 9, 2024+16.30% since signal

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Summary: - Apyx Medical reported a quarterly loss of $0.22 per share. - Revenue for the quarter ended March 2024 was $10.24 million. - Estimate revisions trend for Apyx is unfavorable, with a Zacks Rank #4 (Sell). - Industry rank for Medical-Products is in the top 40% of Zacks industries. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis

Research